Related Experiment Videos

Comparing Non-Laboratory-Based and Laboratory-Based Cardiovascular Risk Predictions: Systematic Review and

Yihun Mulugeta Alemu1,2, Sisay M Alemu3, Nasser Bagheri1,4

  • 1National Centre for Epidemiology and Population Health, College of Health and Medicine Australian National University Canberra Australia.

Health Science Reports
|August 1, 2026
PubMed

Insights

Non-laboratory-based cardiovascular disease (CVD) risk equations show strong agreement with lab-based methods. However, their interchangeability requires context-specific validation and recalibration for accurate risk prediction.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death.
  • Accurate CVD risk assessment is crucial for prevention and management.
  • Evaluating non-laboratory-based risk equations against traditional laboratory-based ones is important for diverse clinical settings.

Purpose of the Study:

  • To assess the agreement between non-laboratory-based and laboratory-based cardiovascular disease (CVD) risk equations.
  • To analyze the concordance of these equations across various global settings.
  • To determine the reliability and potential interchangeability of simplified CVD risk prediction tools.

Main Methods:

  • Systematic literature search across major databases (PubMed, Scopus, Web of Science, etc.) up to March 2025.
  • Meta-analysis using mixed-effects meta-regression on 33 identified studies (243,587 participants).
  • Agreement measured using Spearman correlation coefficient and Kappa statistics.

Main Results:

  • Pooled Spearman correlation was 0.954 and pooled kappa was 0.64, indicating strong agreement between equation types.
  • Higher correlations observed in studies before 2000, high-income settings, and for equations predicting fatal outcomes only.
  • Significant heterogeneity (I²=100% for correlation, I²=99% for kappa) noted across studies.

Conclusions:

  • Non-laboratory-based CVD risk equations demonstrate strong correlation and substantial agreement with laboratory-based equations.
  • Despite high concordance, predictive equivalence is not guaranteed; context-specific validation and recalibration are necessary for implementation.
  • The findings support the potential utility of non-laboratory-based equations but highlight the need for careful consideration of their application.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...